112 related articles for article (PubMed ID: 15881389)
1. [Further development (MDCK) of live cold-adapted influenza vaccine: cultivation of vaccine strains in production fermenters].
Gendon IuZ; Markushin SG; Akopova II; Koptiaeva IB; Nechaeva EA; Mazurkova IA; Radaeva IF; Kolokol'tsova TD
Vopr Virusol; 2005; 50(2):4-9. PubMed ID: 15881389
[TBL] [Abstract][Full Text] [Related]
2. Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine.
Ghendon YZ; Markushin SG; Akopova II; Koptiaeva IB; Nechaeva EA; Mazurkova LA; Radaeva IF; Kolokoltseva TD
Vaccine; 2005 Sep; 23(38):4678-84. PubMed ID: 16026905
[TBL] [Abstract][Full Text] [Related]
3. [Development of a live culture of cold-adapted reassortant influenza vaccines].
Gendon IuZ; Markushin SG; Akopova II; Koptiaeva NB; Isachenko AA; Mazurkova NA; Nechaeva EA
Vopr Virusol; 2003; 48(2):12-7. PubMed ID: 12924092
[TBL] [Abstract][Full Text] [Related]
4. Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
Palker T; Kiseleva I; Johnston K; Su Q; Toner T; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Wlochowski J; Monteiro J; Kraiouchkine N; DiStefano D; Rudenko L; Shaw A; Youil R
Virus Res; 2004 Oct; 105(2):183-94. PubMed ID: 15351492
[TBL] [Abstract][Full Text] [Related]
5. Use of MDCK cells for production of live attenuated influenza vaccine.
Liu J; Shi X; Schwartz R; Kemble G
Vaccine; 2009 Oct; 27(46):6460-3. PubMed ID: 19559113
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of production of reassortant of epidemic strains and cold-adapted influenza viruses in chicken embryo and MDCK cells].
Kiseleva IV; Isakova IN; Larionova NV; Oleĭnik ES; Rudenko LG
Zh Mikrobiol Epidemiol Immunobiol; 2007; (6):40-5. PubMed ID: 18283733
[TBL] [Abstract][Full Text] [Related]
7. [Genetic and phenotypic analysis of heterogeneous population of a cold-adapted donor of the A/Leningrad/134/17/57 (H2N2) attenuation and of the donor-based reassortant influenza vaccine strains].
Kiseleva IV; Klimov AI; Grigor'eva EP; Larionova NV; Aleksandrova GI; Rudenko LG
Vopr Virusol; 2005; 50(2):14-8. PubMed ID: 15881391
[TBL] [Abstract][Full Text] [Related]
8. Genetic engineering of live attenuated influenza viruses.
Jin H; Chen Z; Liu J; Kemble G
Methods Mol Biol; 2012; 865():163-74. PubMed ID: 22528159
[TBL] [Abstract][Full Text] [Related]
9. Cell-based assay for the determination of temperature sensitive and cold adapted phenotypes of influenza viruses.
Kiseleva I; Su Q; Toner TJ; Szymkowiak C; Kwan WS; Rudenko L; Shaw AR; Youil R
J Virol Methods; 2004 Mar; 116(1):71-8. PubMed ID: 14715309
[TBL] [Abstract][Full Text] [Related]
10. Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium.
Voeten JT; Brands R; Palache AM; van Scharrenburg GJ; Rimmelzwaan GF; Osterhaus AD; Claas EC
Vaccine; 1999 Apr; 17(15-16):1942-50. PubMed ID: 10217593
[TBL] [Abstract][Full Text] [Related]
11. A Vero-cell-adapted vaccine donor strain of influenza A virus generated by serial passages.
Hu W; Zhang H; Han Q; Li L; Chen Y; Xia N; Chen Z; Shu Y; Xu K; Sun B
Vaccine; 2015 Jan; 33(2):374-81. PubMed ID: 25448099
[TBL] [Abstract][Full Text] [Related]
12. [Live influenza vaccine: laboratory markers of attenuation].
Isakova IN; Kiseleva IV; Larionova NV; Oleĭnik ES; Rudenko LG
Vopr Virusol; 2007; 52(4):22-6. PubMed ID: 17722606
[TBL] [Abstract][Full Text] [Related]
13. [Influenza virus reproduction in the MDCK cells adapted to growth in serum-free Hybris-2 medium].
Podcherniaeva RIa; Baklanova OV; Glushchenko LA; Isaeva EI; Chestkov VV; Tabakov VIu; Mikhaĭlova GR
Vopr Virusol; 2010; 55(5):47-9. PubMed ID: 21260998
[TBL] [Abstract][Full Text] [Related]
14. Increase in viral yield in eggs and MDCK cells of reassortant H5N1 vaccine candidate viruses caused by insertion of 38 amino acids into the NA stalk.
Zhang W; Xue T; Wu X; Zhang P; Zhao G; Peng D; Hu S; Wang X; Liu X; Liu W; Liu X
Vaccine; 2011 Oct; 29(45):8032-41. PubMed ID: 21864614
[TBL] [Abstract][Full Text] [Related]
15. [The temperature sensitivity of epidemic influenza A viruses as a marker of immunogenicity of reassortant vaccinal strains].
Kiseleva IV; Grigor'eva EP; Naĭkhin AN; Ivanova VV; Larionova NV; Donina SA; Litvinova OM; Aleksandrova GI; Rudenko LG
Vopr Virusol; 2003; 48(4):26-9. PubMed ID: 12945203
[TBL] [Abstract][Full Text] [Related]
16. [Use of plant-origin components in roller cultivation of vaccine reassortant influenza virus strain H5N2].
Mazurkova NA; Desheva IuA; Shishkina LN; Stavskiĭ EA; Rudenko LG
Zh Mikrobiol Epidemiol Immunobiol; 2011; (2):88-92. PubMed ID: 21598624
[TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of attenuation markers of cold-adapted X-31 influenza live vaccine donor strain.
Jang YH; Jung EJ; Lee KH; Byun YH; Yang SW; Seong BL
Vaccine; 2016 Mar; 34(11):1343-9. PubMed ID: 26851733
[TBL] [Abstract][Full Text] [Related]
18. [Genetic stability of cold-adapted influenza viruses].
Kiseleva IV; Larionova NV; Isakova IN; Rudenko LG
Vopr Virusol; 2006; 51(4):13-6. PubMed ID: 16929592
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic and genetic analyses of the heterogeneous population present in the cold-adapted master donor strain: A/Leningrad/134/17/57 (H2N2).
Youil R; Kiseleva I; Kwan WS; Szymkowiak C; Toner TJ; Su Q; Klimov A; Rudenko L; Shaw AR
Virus Res; 2004 Jun; 102(2):165-76. PubMed ID: 15084398
[TBL] [Abstract][Full Text] [Related]
20. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
